Evaluation of Hybridization Capture Versus Amplicon‐Based Methods for Whole‐Exome Sequencing-Reference-Cited by-同舟云学术

Evaluation of Hybridization Capture Versus Amplicon‐Based Methods for Whole‐Exome Sequencing

Published:2015-07-15 Issue:9 Volume:36 Page:903-914
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Human Mutation

Author:

Samorodnitsky Eric¹,Jewell Benjamin M.¹,Hagopian Raffi¹,Miya Jharna¹,Wing Michele R.¹,Lyon Ezra¹,Damodaran Senthilkumar¹²,Bhatt Darshna¹,Reeser Julie W.¹,Datta Jharna¹,Roychowdhury Sameek¹²³

Affiliation:

1. Comprehensive Cancer Center The Ohio State University Columbus Ohio 43210

2. Division of Medical Oncology Department of Internal Medicine The Ohio State University Columbus Ohio 43210

3. Department of Pharmacology The Ohio State University Columbus Ohio 43210

Funder

American Cancer Society

Fore Cancer Research Foundation

National Human Genome Research Institute

Pelotonia

Prostate Cancer Foundation

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/humu.22825

Reference34 articles.

1. Direct selection of human genomic loci by microarray hybridization

2. Comprehensive comparison of three commercial human whole-exome capture platforms

3. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

4. Shining a Light on Dark Sequencing: Characterising Errors in Ion Torrent PGM Data

5. Performance comparison of four exome capture systems for deep sequencing

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct whole-genome sequencing of HIV-1 for clinical drug-resistance analysis and public health surveillance;Journal of Clinical Virology;2024-10

2. An overview of molecular testing in malignancies of the female genital tract;Diagnostic Histopathology;2024-09

3. RNA exon editing: Splicing the way to treat human diseases;Molecular Therapy - Nucleic Acids;2024-09

4. Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study;Neuro-Oncology;2024-08-07

5. Recommendations for Tumor Mutational Burden Assay Validation and Reporting;The Journal of Molecular Diagnostics;2024-08